3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide

C27H33ClN6OS — CID 3990500

IUPAC3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide
SMILESCc1ccccc1N1CCN(c2cc(Cl)nc(SCc3cccc(C(=O)NCCN(C)C)c3)n2)CC1
InChIInChI=1S/C27H33ClN6OS/c1-20-7-4-5-10-23(20)33-13-15-34(16-14-33)25-18-24(28)30-27(31-25)36-19-21-8-6-9-22(17-21)26(35)29-11-12-32(2)3/h4-10,17-18H,11-16,19H2,1-3H3,(H,29,35)
InChIKeyBXXVDXVNUAVFBV-UHFFFAOYSA-N
MW525.12 g/mol
LogP4.35
Rot. Bonds9

About 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide

3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide (PubChem CID 3990500) has the molecular formula C27H33ClN6OS and a molecular weight of 525.12 g/mol. Its IUPAC name is 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide.

Molecular Properties

Compound Name3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide
PubChem CID3990500
Molecular FormulaC27H33ClN6OS
Molecular Weight525.12 g/mol
Exact Mass524.21
IUPAC Name3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide
SMILESCc1ccccc1N1CCN(c2cc(Cl)nc(SCc3cccc(C(=O)NCCN(C)C)c3)n2)CC1
InChIInChI=1S/C27H33ClN6OS/c1-20-7-4-5-10-23(20)33-13-15-34(16-14-33)25-18-24(28)30-27(31-25)36-19-21-8-6-9-22(17-21)26(35)29-11-12-32(2)3/h4-10,17-18H,11-16,19H2,1-3H3,(H,29,35)
InChIKeyBXXVDXVNUAVFBV-UHFFFAOYSA-N
XLogP4.35
TPSA64.60 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500525.12
LogP ≤ 54.35
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide?
The IUPAC name of 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide (CID 3990500) is 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide.
What is the SMILES notation for 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide?
The canonical SMILES for 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide is Cc1ccccc1N1CCN(c2cc(Cl)nc(SCc3cccc(C(=O)NCCN(C)C)c3)n2)CC1.
What is the InChIKey of 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide?
The InChIKey is BXXVDXVNUAVFBV-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33ClN6OS/c1-20-7-4-5-10-23(20)33-13-15-34(16-14-33)25-18-24(28)30-27(31-25)36-19-21-8-6-9-22(17-21)26(35)29-11-12-32(2)3/h4-10,17-18H,11-16,19H2,1-3H3,(H,29,35).
What are the key properties of 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide?
3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide has a molecular weight of 525.12 g/mol, XLogP of 4.35, 9 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[4-chloro-6-[4-(2-methylphenyl)piperazin-1-yl]pyrimidin-2-yl]sulfanylmethyl]-N-[2-(dimethylamino)ethyl]benzamide is sourced from PubChem (CID 3990500), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).